Form 4: Sutro Biopharma Executive Exercises Stock Options and Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Venkatesh Srinivasan, Chief Technical Operations Officer of Sutro Biopharma, exercised stock options and disposed of shares to cover tax obligations on May 1, 2024.
Summary
- On May 1, 2024, Venkatesh Srinivasan, the Chief Technical Operations Officer of Sutro Biopharma, exercised restricted stock units (RSUs) converting them into 2,500 shares of common stock.
- Simultaneously, Srinivasan disposed of 892 shares of common stock at a price of $3.74 to satisfy income tax withholding obligations related to the RSU settlement.
- Following these transactions, Srinivasan directly owns 31,730 shares of Sutro Biopharma common stock and 7,500 restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of transaction: Exercise of RSUs and disposal of shares for tax obligations. |
| 05/01/2027 | Expiration date of the Restricted Stock Units. |
| 05/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.